Keith Manchester

Insider Reports History

Entity
Individual
Location
C/O Roivant Sciences Ltd., 11 12 St. James's Square Suite 1, 3 Rd Fl, London, United Kingdom
Signature
/s/ Keith Manchester
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith Manchester:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Roivant Sciences Ltd. Director Common Shares 1.28M $15M $11.77 Sep 25, 2024 Direct
Arbutus Biopharma Corp Director Common Shares 46.1K $170K $3.69 Aug 14, 2024 Direct
Roivant Sciences Ltd. Director Stock Option (Right to Buy) 27.9K Sep 10, 2024 Direct
Arbutus Biopharma Corp Director Stock Option (Right to Buy) 0 Aug 14, 2024 Direct

Insider Reports Filed by Keith Manchester

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ROIV Roivant Sciences Ltd. Sep 24, 2024 2 -$5.87M 4 Sep 26, 2024 Director
ROIV Roivant Sciences Ltd. Sep 10, 2024 2 $0 4 Sep 12, 2024 Director
ABUS Arbutus Biopharma Corp Aug 14, 2024 3 -$1.88K 4 Aug 16, 2024 Director
ABUS Arbutus Biopharma Corp May 23, 2024 1 $0 4 May 24, 2024 Director
ROIV Roivant Sciences Ltd. Mar 7, 2024 4 $0 4 Mar 7, 2024 Director
ROIV Roivant Sciences Ltd. Sep 28, 2023 4 -$79.7M 4 Oct 2, 2023 Director
ROIV Roivant Sciences Ltd. Sep 12, 2023 2 $0 4 Sep 14, 2023 Director
ABUS Arbutus Biopharma Corp May 24, 2023 1 $0 4 May 26, 2023 Director
ROIV Roivant Sciences Ltd. Nov 9, 2022 5 -$18.6M 4 Nov 14, 2022 Director
ROIV Roivant Sciences Ltd. Sep 15, 2022 2 $0 4 Sep 19, 2022 Director
ABUS Arbutus Biopharma Corp May 25, 2022 1 $0 4 May 26, 2022 Director
ROIV Roivant Sciences Ltd. Oct 1, 2021 0 $0 3 Oct 1, 2021 Director
ABUS Arbutus Biopharma Corp Jun 3, 2021 1 $0 4 Jun 7, 2021 Director